Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.71 |
| ▸ | MAOB | P27338 | 6/20 | 0.68 |
| ▸ | BCHE | P06276 | 1/20 | 0.68 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.63 |
| ▸ | APP | P05067 | 1/20 | 0.60 |
| ▸ | MAOA | P21397 | 4/20 | 0.59 |
| ▸ | FBP1 | P09467 | 1/20 | 0.58 |
| ▸ | RHOA | P61586 | 1/20 | 0.57 |
| ▸ | HCAR2 | Q8TDS4 | 2/20 | 0.57 |
| ▸ | CA12 | O43570 | 1/20 | 0.57 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.57 |
| ▸ | CA1 | P00915 | 1/20 | 0.57 |
| ▸ | CA2 | P00918 | 1/20 | 0.57 |
| ▸ | ESR1 | P03372 | 1/20 | 0.57 |
| ▸ | CA3 | P07451 | 1/20 | 0.57 |
| ▸ | PKM | P14618 | 1/20 | 0.57 |
| ▸ | TYR | P14679 | 1/20 | 0.57 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.57 |
| ▸ | CA4 | P22748 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL42325 | 1.00 | MEN1 (0.71) | MEN1KMT2AMAOBBCHECYP1B1 | |
| Benzene SCHEMBL6915910 | 0.98 | MAOB (0.71) | MEN1KMT2AMAOBBCHECYP1B1 | |
| SCHEMBL29077145 | 0.98 | MEN1 (0.69) | MEN1KMT2AMAOBBCHECYP1B1 | |
| SCHEMBL27867390 | 0.98 | MEN1 (0.69) | MEN1KMT2AMAOBBCHECYP1B1 | |
| SCHEMBL27883557 | 0.98 | MEN1 (0.69) | MEN1KMT2AMAOBBCHECYP1B1 | |
| Hydrochloric Acid SCHEMBL4989762 | 0.98 | MEN1 (0.69) | MEN1KMT2AMAOBBCHECYP1B1 | |
| SCHEMBL11836065 | 0.95 | MEN1 (0.65) | MEN1KMT2AMAOBBCHECYP1B1 | |
| SCHEMBL11836067 | 0.95 | MEN1 (0.65) | MEN1KMT2AMAOBBCHECYP1B1 | |
| SCHEMBL17457069 | 0.92 | MAOB (0.63) | MEN1KMT2AMAOBBCHECYP1B1 | |
| Alcohol SCHEMBL8131569 | 0.92 | MEN1 (0.66) | MEN1KMT2AMAOBBCHECYP1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 903 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122070479-A | Ultrasonic indicating device and method for monitoring ultrasonic treatment | JP实验室股份有限公司 | 2026-05-19 | — | — | CN | claimed |
| US-12497636-B2 | Recombinant Saccharomyces cerevisiae cells for cannabinoid production | NATIONAL UNIVERSITY OF SINGAPORE (SG) | 2025-12-16 | — | — | US | claimed |
| US-12365830-B2 | Ligand-exchangeable janus nanoparticles and methods of making the same | ALLIANCE FOR SUSTAINABLE ENERGY, LLC (US) | 2025-07-22 | — | — | US | claimed |
| CN-120082047-A | Porous coordination polymer and preparation method and application thereof | 中国石油化工股份有限公司 | 2025-06-03 | — | — | CN | claimed |
| WO-2025090061-A1 | ULTRASONIC INDICATOR DEVICE AND METHOD FOR MONITORING ULTRASONICATION | JP LABORATORIES, INC. (US) | 2025-05-01 | — | — | WO | claimed |
| WO-2025075611-A1 | ULTRASONIC INDICATOR BASED ON EMULSION FORMATION | JP LABORATORIES, INC. (US) | 2025-04-10 | — | — | WO | claimed |
| CN-119192075-A | Cinnamic acid derivative and preparation method thereof | 广东工业大学 | 2024-12-27 | — | — | CN | claimed |
| CN-119080437-A | High-strength wear-resistant asphalt concrete and production process thereof | 河北路达凯亚环保科技有限公司 | 2024-12-06 | — | — | CN | claimed |
| CN-118930507-A | Baicalein derivative and preparation method and application thereof | 上海中医药大学 | 2024-11-12 | — | — | CN | claimed |
| CN-111801420-B | Method for producing 4-amino cinnamic acid, and vector and host cell therefor | 国立研究开发法人科学技术振兴机构 | 2023-10-24 | — | — | CN | claimed |
| US-6946025-B2 | Process for preparing tetra-amide compounds | XEROX CORPORATION (US) | 2005-09-20 | — | — | US | claimed |
| US-20050161666-A1 | Photosensitive semiconductor nanocrystals, photosensitive composition comprising semiconductor nanocrystals and method for forming semiconductor nanocrystal pattern using the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2005-07-28 | — | — | US | claimed |
| US-20050090690-A1 | Process for preparing tetra-amide compounds | XEROX CORPORATION | 2005-04-28 | — | — | US | claimed |
| EP-1526584-A2 | Photosensitive semiconductor nanocrystals, photosensitive composition comprising semiconductor nanocrystals and method for forming semiconductor nanocrystal pattern using the same | Samsung Electronics Co., Ltd (KR) | 2005-04-27 | — | — | EP | claimed |
| US-6602679-B2 | Substrate of an oxidant, stabilizer and buffer with an extended shelf life is useful with enzyme based probes; detecting DNA fragments in DNA sequencing | GIRI BRIJ (US) | 2003-08-05 | — | — | US | claimed |
| US-20010046688-A1 | Novel stabilized formulations for chemiluminescent assays | GIRI BRIJ PAL (US) | 2001-11-29 | — | — | US | claimed |
| WO-2001055446-A1 | NOVEL STABILIZED FORMULATIONS FOR CHEMILUMINESCENT ASSAYS | GIRI BRIJ PAL (US) | 2001-08-02 | — | — | WO | claimed |
| EP-0166542-B1 | TRITERPENYL ESTERS OF ORGANIC ACIDS, PROCESS FOR THEIR PRODUCTION, AND HYPOLIPIDEMIC AGENTS COMPOSED OF THEM | AMANO PHARMACEUTICAL CO., LTD. (JP) | 1990-08-08 | — | — | EP | claimed |
| US-4748161-A | Triterpenyl esters of organic acids and hypolipidemic agents composed of them | AMANO PHARMACEUTICAL CO., LTD. (JP) | 1988-05-31 | — | — | US | claimed |
| EP-0166542-A2 | Triterpenyl esters of organic acids, process for their production, and hypolipidemic agents composed of them | AMANO PHARMACEUTICAL CO., LTD. (JP) | 1986-01-02 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050090690-A1 | Process for preparing tetra-amide compounds | TAF9, TAF5, TAF1 | MEN1 1466/4885KMT2A 826/4885MAOB 1285/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.